Antigen-specific Modulation of an Immune Response by in Vivo Administration of Soluble MHC Class I Tetramers
Overview
Affiliations
Soluble MHC/peptide tetramers that can directly bind the TCR allow the direct visualization and quantitation of Ag-specific T cells in vitro and in vivo. We used HY-D(b) tetramers to assess the numbers of HY-reactive CD8+ T cells in HYTCR-transgenic mice and in naive, wild-type C57BL/6 (B6) mice. As expected, tetramer staining showed the majority of T cells were male-specific CD8+ T cells in female HY-TCR mice. Staining of B6 mice showed a small population of male-specific CD8+ T cells in female mice. The effect of administration of soluble MHC class I tetramers on CD8+ T cell activation in vivo was unknown. Injection of HY-D(b) tetramer in vivo effectively primed female mice for a more rapid proliferative response to both HY peptide and male splenocytes. Furthermore, wild-type B6 female mice injected with a single dose of HY-D(b) tetramer rejected B6 male skin grafts more rapidly than female littermates treated with irrelevant tetramer. In contrast, multiple doses of HY-D(b) tetramer did not further decrease graft survival. Rather, female B6 mice injected with multiple doses of HY-D(b) tetramer rejected male skin grafts more slowly than mice primed with a single injection of tetramer or irradiated male spleen cells, suggesting clonal exhaustion or anergy. Our data highlight the ability of soluble MHC tetramers to identify scarce alloreactive T cell populations and the use of such tetramers to directly modulate an Ag-specific T cell response in vivo.
Virus-Specific T-Cell Therapy for the Management of Viral Infections in the Immunocompromised.
Koukoulias K, Papayanni P, Leen A, Vasileiou S Transfus Med Hemother. 2025; 52(1):5-26.
PMID: 39944414 PMC: 11813280. DOI: 10.1159/000540961.
MHC multimer: A Molecular Toolbox for Immunologists.
Chang J Mol Cells. 2021; 44(5):328-334.
PMID: 33972472 PMC: 8175149. DOI: 10.14348/molcells.2021.0052.
Garcia-Rios E, Nuevalos M, Mancebo F, Perez-Romero P Front Immunol. 2021; 12:657144.
PMID: 33968058 PMC: 8104120. DOI: 10.3389/fimmu.2021.657144.
Soluble MHC class I complexes for targeted immunotherapy.
Schappert A, Schneck J, Suarez L, Oelke M, Schutz C Life Sci. 2018; 209:255-258.
PMID: 30102903 PMC: 6149538. DOI: 10.1016/j.lfs.2018.08.023.
Wang W, Shahzad K, Li M, Zhang A, Zhang L, Xu T Front Immunol. 2017; 8:657.
PMID: 28649247 PMC: 5465244. DOI: 10.3389/fimmu.2017.00657.